Clovis Oncology Cash on Hand 2010-2019 | CLVS

Clovis Oncology cash on hand from 2010 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Clovis Oncology Annual Cash on Hand
(Millions of US $)
2018 $520
2017 $564
2016 $266
2015 $529
2014 $483
2013 $323
2012 $144
2011 $140
2010 $22
2009 $
Clovis Oncology Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $354
Q2 2019 $316
Q1 2019 $407
Q4 2018 $520
Q3 2018 $604
Q2 2018 $682
Q1 2018 $464
Q4 2017 $564
Q3 2017 $628
Q2 2017 $672
Q1 2017 $409
Q4 2016 $266
Q3 2016 $319
Q2 2016 $379
Q1 2016 $445
Q4 2015 $529
Q3 2015 $606
Q2 2015 $378
Q1 2015 $433
Q4 2014 $483
Q3 2014 $517
Q2 2014 $273
Q1 2014 $304
Q4 2013 $323
Q3 2013 $357
Q2 2013 $372
Q1 2013 $130
Q4 2012 $144
Q3 2012 $162
Q2 2012 $177
Q1 2012 $121
Q4 2011 $140
Q3 2011
Q2 2011
Q1 2011
Q4 2010 $22
Q4 2009
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.387B $0.095B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.118B 15.10
CSL (CSLLY) Australia $83.969B 0.00
Gilead Sciences (GILD) United States $81.336B 10.08
Celgene (CELG) United States $77.805B 11.11
Vertex Pharmaceuticals (VRTX) United States $54.001B 55.12
Biogen (BIIB) United States $50.996B 8.75
Illumina (ILMN) United States $45.080B 49.46
Regeneron Pharmaceuticals (REGN) United States $37.351B 16.35
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.893B 11.80
Seattle Genetics (SGEN) United States $19.834B 0.00
Incyte (INCY) United States $18.845B 43.74
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
Genmab (GNMSF) Denmark $14.056B 62.08
BioMarin Pharmaceutical (BMRN) United States $13.502B 0.00
Exact Sciences (EXAS) United States $10.667B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.338B 0.00
Galapagos (GLPG) Belgium $10.332B 26.62
BeiGene (BGNE) Cayman Islands $9.307B 0.00
QIAGEN (QGEN) Netherlands $9.257B 30.18
Amarin (AMRN) Ireland $8.073B 0.00
Bio-Techne Corp (TECH) United States $8.058B 53.93
Guardant Health (GH) United States $7.399B 0.00
Sarepta Therapeutics (SRPT) United States $7.298B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.942B 0.00
Moderna (MRNA) United States $6.482B 0.00
Reata Pharmaceuticals (RETA) United States $6.275B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.755B 14.63
ARGENX SE-ADR (ARGX) Netherlands $5.392B 0.00
Exelixis (EXEL) United States $4.931B 13.87
Medicines (MDCO) United States $4.676B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Ascendis Pharma (ASND) Denmark $4.508B 0.00
Repligen (RGEN) United States $4.499B 81.54
Spark Therapeutics (ONCE) United States $4.282B 0.00
Bluebird Bio (BLUE) United States $4.150B 0.00
Adaptive Biotechnologies (ADPT) United States $3.748B 0.00
Blueprint Medicines (BPMC) United States $3.668B 0.00
Mirati Therapeutics (MRTX) United States $3.653B 0.00
MorphoSys AG (MOR) Germany $3.563B 0.00
Immunomedics (IMMU) United States $3.442B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.231B 0.00
Alkermes (ALKS) Ireland $3.176B 0.00
Genmab (GMAB) Denmark $2.923B 6.02
Emergent Biosolutions (EBS) United States $2.806B 27.87
Halozyme Therapeutics (HALO) United States $2.767B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.717B 0.00
NeoGenomics (NEO) United States $2.532B 134.72
MyoKardia (MYOK) United States $2.497B 0.00
Amicus Therapeutics (FOLD) United States $2.441B 0.00
UniQure (QURE) Netherlands $2.314B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.27
Acceleron Pharma (XLRN) United States $2.255B 0.00
Zai Lab (ZLAB) China $2.251B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.121B 0.00
Cambrex (CBM) United States $2.017B 25.46
Myriad Genetics (MYGN) United States $1.841B 27.20
Ligand Pharmaceuticals (LGND) United States $1.818B 34.97
Insmed (INSM) United States $1.797B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.514B 0.00
Zymeworks (ZYME) Canada $1.465B 0.00
Denali Therapeutics (DNLI) United States $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.464B 0.00
Epizyme (EPZM) United States $1.404B 0.00
REGENXBIO (RGNX) United States $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.350B 0.00
Coherus BioSciences (CHRS) United States $1.345B 0.00
Innoviva (INVA) United States $1.267B 3.73
Editas Medicine (EDIT) United States $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
Alector (ALEC) United States $1.094B 0.00
Sangamo Therapeutics (SGMO) United States $1.083B 0.00
Fate Therapeutics (FATE) United States $1.081B 0.00
Arvinas (ARVN) United States $1.048B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.997B 0.00
WAVE Life Sciences (WVE) Singapore $0.980B 0.00
Principia Biopharma (PRNB) United States $0.954B 0.00
Athenex (ATNX) United States $0.887B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Codexis (CDXS) United States $0.865B 0.00
Anika Therapeutics (ANIK) United States $0.857B 27.82
Cara Therapeutics (CARA) United States $0.847B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.830B 6.98
Vericel (VCEL) United States $0.824B 307.17
ZIOPHARM Oncology Inc (ZIOP) United States $0.816B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.721B 184.16
Revance Therapeutics (RVNC) United States $0.719B 0.00
Twist Bioscience (TWST) United States $0.691B 0.00
ANI Pharmaceuticals (ANIP) United States $0.678B 11.56
DBV Technologies S.A (DBVT) France $0.671B 0.00
Intellia Therapeutics (NTLA) United States $0.665B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Precision BioSciences (DTIL) United States $0.643B 0.00
Agenus (AGEN) United States $0.604B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Adverum Biotechnologies (ADVM) United States $0.590B 0.00
GENFIT S.A (GNFT) France $0.580B 0.00
Cellectis S.A (CLLS) France $0.565B 0.00
Retrophin (RTRX) United States $0.559B 0.00
BioDelivery Sciences (BDSI) United States $0.545B 0.00
UROGEN PHARMA (URGN) United States $0.545B 0.00
Kadmon Holdings (KDMN) United States $0.536B 0.00
Stemline Therapeutics (STML) United States $0.525B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.493B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.479B 0.00
Intra-Cellular Therapies (ITCI) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 11.02
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.409B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.366B 0.00
Bellus Health (BLU) Canada $0.364B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.344B 8.60
Arcus Biosciences (RCUS) United States $0.336B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Compugen (CGEN) Israel $0.293B 0.00
Avid Bioservices (CDMO) United States $0.291B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Protagonist Therapeutics (PTGX) United States $0.278B 0.00
Pfenex (PFNX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.263B 0.00
Cel-Sci (CVM) United States $0.261B 0.00
Gritstone Oncology (GRTS) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.256B 0.00
Geron (GERN) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.248B 0.00
Theratechnologies (THTX) Canada $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Kamada (KMDA) Israel $0.239B 6.98
OSMOTICA PHARM (OSMT) United States $0.238B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
Inovio Pharmaceuticals (INO) United States $0.228B 0.00
XOMA (XOMA) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.225B 0.00
Athersys (ATHX) United States $0.218B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
Scholar Rock Holding (SRRK) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.209B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Sorrento Therapeutics (SRNE) United States $0.194B 0.00
Exicure (XCUR) United States $0.187B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Spero Therapeutics (SPRO) United States $0.181B 0.00
Palatin Technologies (PTN) United States $0.180B 4.91
CorMedix Inc (CRMD) United States $0.173B 0.00
Dyadic (DYAI) United States $0.171B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Arsanis (XFOR) United States $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Cerecor (CERC) United States $0.137B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
BioTime (LCTX) United States $0.130B 6.65
Ophthotech (ISEE) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Five Prime Therapeutics (FPRX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
NantKwest (NK) United States $0.112B 0.00
Aptinyx (APTX) United States $0.106B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Novavax (NVAX) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Celyad SA (CYAD) Belgium $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Aduro Biotech (ADRO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.080B 0.00
Strongbridge Biopharma (SBBP) United States $0.080B 2.13
Acorda Therapeutics (ACOR) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Verastem (VSTM) United States $0.064B 0.00
Synlogic (SYBX) United States $0.063B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Checkpoint Therapeutics (CKPT) United States $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Orgenesis (ORGS) United States $0.053B 3.39
China Health Industries Holdings (CHHE) China $0.052B 15.78
Applied Genetic Technologies (AGTC) United States $0.051B 0.00
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.032B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
VIVUS (VVUS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
VistaGen Therapeutics (VTGN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Advaxis (ADXS) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00